|
注册号: Registration number: |
ChiCTR-OOC-16010002 |
|
最近更新日期: Date of Last Refreshed on: |
2016-11-24 21:59:34 |
|
注册时间: Date of Registration: |
2016-11-24 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
真实世界急性脑梗死中西医诊治规律研究 |
|
Public title: |
A real world study on the management of acute ischemic stroke using both Chinese traditional medicine and western medical strategy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
真实世界大数据急性脑梗死中西医证治规律研究暨体外血浆净化技术对急性脑卒中个体化治疗研究 |
|
Scientific title: |
A real world study on the management of acute ischemic stroke using both Chinese traditional medicine and western medical strategy including extracorporeal plasmapheresis |
|
研究课题代号(代码): Study subject ID: |
SCEPCM16E002 |
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
杜慧琴 |
研究负责人: |
方邦江 |
|
Applicant: |
DU Huiqin |
Study leader: |
FANG Bangjiang |
|
申请注册联系人电话: Applicant telephone: |
+86 18202158319 |
研究负责人电话:
Study leader's |
+86 18917763257 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
hqdu@imedmaster.com |
研究负责人电子邮件: Study leader's E-mail: |
fangbji@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海浦东新区郭守敬路199号109室 |
研究负责人通讯地址: |
上海市徐汇区宛平南路725号 上海中医药大学附属龙华医院 |
|
Applicant address: |
Room 109, 199 Guoshoujing Road, Pudong, Shanghai |
Study leader's address: |
725 South Wanping Road, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
201203 |
研究负责人邮政编码: Study leader's postcode: |
200032 |
|
申请人所在单位: |
杏汇医疗科技(上海)有限公司 |
||
|
Applicant's institution: |
Xinhui Medtech (Shanghai) Co., Ltd. |
||
|
研究负责人所在单位: |
上海中医药大学附属龙华医院 |
||
|
Affiliation of the Leader: |
Longhua Hospital, Shanghai University of Traditional Chinese Medicine |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2016LCSY037 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海中医药大学附属龙华医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Research Ethics Committee of Longhua Hospital, Shanghai University of Traditional Chinese Medicine |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2016-07-13 00:00:00 | ||
|
伦理委员会联系人: |
|
||
|
Contact Name of the ethic committee: |
|
||
|
伦理委员会联系地址: |
|
||
|
Contact Address of the ethic committee: |
|
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
上海中医药大学附属龙华医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Longhua Hospital, Shanghai University of Traditional Chinese Medicine |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市徐汇区宛平南路725号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
725 South Wanping Road, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
世界中医药学会联合会 |
||||||||||||||||||||||
|
Source(s) of funding: |
World Federation of Chinese Medicine Societies |
||||||||||||||||||||||
|
研究疾病: |
急性缺血性脑卒中 |
||||||||||||||||||||||
|
Target disease: |
Acute ischemic stroke |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
单臂 |
||||||||||||||||||||||
|
Study design: |
Single arm |
||||||||||||||||||||||
|
研究目的: |
本课题以医疗大数据为基础,采用大数据统计分析和实际病例验证的方法,开展面向急性脑卒中的不同中医证型分析,以及体外血液净化治疗的疗效与预后的数据分析技术研究,包括对脑卒中的特征提取、不同中医证型早期征兆识别以及高危人群甄别的数据分析方法与技术,同时探讨不同中医证型的脑卒中及合并症转归的数据特征及不同中医证型脑卒中体外血液净化治疗的治疗效果与预后。 |
||||||||||||||||||||||
|
Objectives of Study: |
The study will conduct a real world study based big data analysis, to research the characteristics of TCM and western medicine diagnosis and treatment(including extracorporeal plasmapheresis) of acute ischemic stroke, including features extraction and early identification method of TCM Syndrome Types in acute ischemic stroke, patients in high risk identification and the relationship between TCM Syndrome Types and the effect and outcome of extracorporeal plasmapheresis in acute ischemic stroke treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1)由于共病的存在预计生存期不足6个月者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Life expectancy less than 6 months due to comorbidities; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2016-07-14 00:00:00至 To 2019-07-13 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2016-12-01 00:00:00 至 To 2019-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无随机化 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
No randomization |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
|
|
Blinding: |
|
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
研究完成后6个月内公开 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
six months after the study complete |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
openclinica |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
openclinica |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |